Non-ownership Filings
| Board Committee Change | Mar. 09, 2026 |
| GSK and Alfasigma agree global linerixibat rights | Mar. 09, 2026 |
| Filing of GSK plc 2025 Annual Report on Form 20-F | Mar. 06, 2026 |
| GSK completes acquisition of RAPT Therapeutics | Mar. 03, 2026 |
| Total Voting Rights | Mar. 02, 2026 |
| Linerixibat accepted for priority review in China | Feb. 26, 2026 |
| Bepirovirsen accepted for Japan regulatory review | Feb. 26, 2026 |
Ownership Update Filings
| Director/PDMR Shareholding | Mar. 12, 2026 |
| Transaction in Own Shares | Mar. 12, 2026 |
| Transaction in Own Shares | Mar. 11, 2026 |
| Transaction in Own Shares | Mar. 10, 2026 |
| Transaction in Own Shares | Mar. 09, 2026 |
| Transaction in Own Shares | Mar. 06, 2026 |
| Director/PDMR Shareholding | Mar. 04, 2026 |